Clinical Trials Blog

May 2025 clinical trial highlights

by Pulmonary Fibrosis Foundation
May 20, 2025

Clinical trial participants are essential in the quest for new treatments and a cure for pulmonary fibrosis (PF).

In the May 2025 clinical trial highlights, we'll showcase just a few of the many trials that are enrolling volunteers. To view more available trials for various forms of interstitial lung disease (ILD), please visit the 🔍 PFF Clinical Trial Finder.

Seeking participants with IPF

ALOFT-IPF

Seeking participants with IPF

DWN12088 in IPF

Seeking participants with SSc-ILD

Efzofitimod in SSc-ILD

Seeking participants with fibrotic ILD

Pulmonary Rehabilitation and Health Coaching in Fibrotic ILD

  • Study ID: NCT06751069
  • Intervention: Home-based pulmonary rehabilitation
  • Sponsor: Mayo Clinic
  • Study Contact: Johanna Hoult, MS hoult.johanna@mayo.edu; 507.293.1989
  • Learn more about this study

 

When Mario started feeling out of breath during a trip to South America, he thought his breathing difficulties were caused by wearing a mask in the heat. When he returned home, he went to see his doctor just to make sure.Hearing the diagnosis of idiopathic pulmonary fibrosis (IPF) was devastating. He researched the disease on the internet but only found bad news.

Then he discovered the support and resources provided by the PFF, and his whole outlook changed. He decided he wasn’t going to let IPF stop him from enjoying life. He is determined to travel and spend time with family and friends while he savors every moment. Today, Mario raises awareness of IPF and campaigns for a cure as a PFF Ambassador.

Participating in IPF research helps the scientific discovery process for people like Mario. To learn more about IPF, visit the IPF webpage.

 

RSVP for the PFF's Clinical Trial Webinar Series in June

On Wednesday, June 4, 2025, from noon to 1 p.m. CT, join the PFF and industry representatives for the second webinar in the PFF Clinical Trial Innovation (CTI) Webinar Series. Speakers will talk about the following trials underway to help find new treatments for PF and ILD.

  • Trial Sponsor: Vicore Pharma AB
  • Speaker: James Nolin, PhD; Senior Clinical Science Liaison at Vicore Pharma AB
  • Trial Sponsor: Boehringer Ingelheim
  • Speaker: Thomas Porter, MBA, MPH; Director, Clinical Development Lead at Boehringer Ingelheim

PFF Community Registry
  • Trial Sponsor: Pulmonary Fibrosis Foundation
  • Speaker: Jessica Shore, PhD, RN; Senior Vice President, Clinical Affairs and Quality at PFF